Oppenheimer analyst Hartaj Singh assigned a Buy rating to Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price

Oppenheimer analyst Hartaj Singh assigned a Buy rating to Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price
In a report released yesterday, Jason McCarthy from Maxim Group maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals
After Oppenheimer and Merrill Lynch gave Vertex Pharmaceuticals (NASDAQ: VRTX) a Buy rating last month, the company received another Buy,
Oppenheimer analyst Hartaj Singh assigned a Buy rating to Vertex Pharmaceuticals (VRTX – Research Report) today and set a price
In a report issued on October 30, Jason McCarthy from Maxim Group reiterated a Hold rating on Vertex Pharmaceuticals (VRTX
Analysts fell to the sidelines weighing in on Vertex Pharmaceuticals (VRTX – Research Report) and AxoGen (AXGN – Research Report)